216 related articles for article (PubMed ID: 12607392)
1. [Osteoporosis].
Bartl R
Internist (Berl); 2002 Dec; 43(12):1529-30, 1533-43. PubMed ID: 12607392
[No Abstract] [Full Text] [Related]
2. Osteoporosis: which current treatments reduce fracture risk?
Baran DT
Cleve Clin J Med; 2000 Oct; 67(10):701-3. PubMed ID: 11060956
[TBL] [Abstract][Full Text] [Related]
3. Summaries for patients. Drug therapy for osteoporosis.
Ann Intern Med; 2008 May; 148(9):I28. PubMed ID: 18458273
[No Abstract] [Full Text] [Related]
4. Long-term experience with alendronate in the treatment of osteoporosis.
Hochberg MC; Rizzoli R
Expert Opin Pharmacother; 2006 Jun; 7(9):1201-10. PubMed ID: 16732706
[TBL] [Abstract][Full Text] [Related]
5. Treating osteoporosis in post-menopausal women: a case approach.
Keller MI
Cleve Clin J Med; 2004 Oct; 71(10):829-37. PubMed ID: 15529489
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological interventions for the prevention of vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: does site-specificity exist?
Compston JE
Bone; 2000 Dec; 27(6):765-8. PubMed ID: 11113386
[No Abstract] [Full Text] [Related]
7. Parathyroid hormone.
Madore GR; Sherman PJ; Lane JM
J Am Acad Orthop Surg; 2004; 12(2):67-71. PubMed ID: 15089079
[No Abstract] [Full Text] [Related]
8. An approach to postmenopausal osteoporosis treatment: a case study review.
Kessenich C
J Am Acad Nurse Pract; 2003 Dec; 15(12):539-45. PubMed ID: 14983569
[TBL] [Abstract][Full Text] [Related]
9. Osteoporosis management in the new millennium.
Wei GS; Jackson JL; Hatzigeorgiou C; Tofferi JK
Prim Care; 2003 Dec; 30(4):711-41, vi-vii. PubMed ID: 15024893
[TBL] [Abstract][Full Text] [Related]
10. Evidence-based medicine: putting theory into practice.
Irani M
Hosp Med; 2001 Mar; 62(3):164-8. PubMed ID: 11291467
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of osteoporosis in the elderly: what is the evidence?].
Verhaar HJ
Tijdschr Gerontol Geriatr; 2008 Oct; 39(5):168-75. PubMed ID: 18975841
[TBL] [Abstract][Full Text] [Related]
12. Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis--usefulness of alendronate and risedronate.
Iwamoto J; Takeda T; Sato Y
Expert Opin Pharmacother; 2007 Nov; 8(16):2743-56. PubMed ID: 17956196
[TBL] [Abstract][Full Text] [Related]
13. Oral antiresorptive therapy.
Pande I; Hosking DJ
Curr Osteoporos Rep; 2004 Dec; 2(4):116-22. PubMed ID: 16036092
[TBL] [Abstract][Full Text] [Related]
14. Medications for postmenopausal osteoporosis prevention.
Harv Womens Health Watch; 2002 Dec; 10(4):6-7. PubMed ID: 12499127
[No Abstract] [Full Text] [Related]
15. Gastroenterologists and choosing the right bisphosphonate.
Leder BZ; Kronenberg HM
Gastroenterology; 2000 Sep; 119(3):866-9. PubMed ID: 10982780
[No Abstract] [Full Text] [Related]
16. [Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?].
MMW Fortschr Med; 2004 May; 146(21):63. PubMed ID: 15373093
[No Abstract] [Full Text] [Related]
17. Prevention and treatment of osteoporosis.
Lloyd M
Clin Med (Lond); 2001; 1(2):155-6. PubMed ID: 11333463
[No Abstract] [Full Text] [Related]
18. Role of alendronate and risedronate in preventing and treating osteoporosis.
Peters ML; Leonard M; Licata AA
Cleve Clin J Med; 2001 Nov; 68(11):945-51. PubMed ID: 11718433
[TBL] [Abstract][Full Text] [Related]
19. [To increase bone density faster and stronger].
MMW Fortschr Med; 2005 May; 147(18):44-5. PubMed ID: 15934589
[No Abstract] [Full Text] [Related]
20. Bisphosphonate therapy.
Licata AA
Am J Med Sci; 1997 Jan; 313(1):17-22. PubMed ID: 9001162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
